TCT-312 The Impact of Platelet-Fibrin Clot Strength and Endogenous Fibrinolytic Activity on Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients with Coronary Artery Disease

TEG® system indicates “Platelet-Fibrin Clot Strength” (MAthrombin: maximal amplitude of the clot dynamics) and endogenous fibrinolytic activity (LY30: percentage of the clot lysis at 30 min) together. Conclusion This study is the first to show the clinical impact of clot strength and endogenous fibr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B128-B129
Hauptverfasser:	Ahn, Jong-Hwa, Jeong, Young-Hoon
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty Blood platelets Cardiology Cardiovascular disease Coronary artery Coronary artery disease Fibrin Health risk assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!